HK1005876A1 - 17B-(3-furyl) and 17B-(4-pyridazinyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same - Google Patents
17B-(3-furyl) and 17B-(4-pyridazinyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing sameInfo
- Publication number
- HK1005876A1 HK1005876A1 HK98104942A HK98104942A HK1005876A1 HK 1005876 A1 HK1005876 A1 HK 1005876A1 HK 98104942 A HK98104942 A HK 98104942A HK 98104942 A HK98104942 A HK 98104942A HK 1005876 A1 HK1005876 A1 HK 1005876A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- pyridazinyl
- furyl
- pharmaceutical compositions
- compositions containing
- 14beta
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 210000000748 cardiovascular system Anatomy 0.000 title 1
- 230000026676 system process Effects 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring the nitrogen atom being directly linked to the cyclopenta(a)hydro phenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J17/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
- C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
- C07J41/0088—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 containing unsubstituted amino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J43/00—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J43/003—Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
- C07J71/001—Oxiranes
- C07J71/0021—Oxiranes at position 14(15)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Heart & Thoracic Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4227616A DE4227616C2 (de) | 1992-08-20 | 1992-08-20 | 17-(3-Furyl)-und 17-(4-Pyridazinyl)-5beta, 14beta-androstanderivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammemsetzungen |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1005876A1 true HK1005876A1 (en) | 1999-01-29 |
Family
ID=6465993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK98104942A HK1005876A1 (en) | 1992-08-20 | 1998-06-05 | 17B-(3-furyl) and 17B-(4-pyridazinyl)-5beta 14beta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same |
Country Status (12)
Country | Link |
---|---|
US (2) | US5591734A (xx) |
EP (1) | EP0583578B1 (xx) |
JP (2) | JP3357427B2 (xx) |
KR (1) | KR100276528B1 (xx) |
AT (1) | ATE152118T1 (xx) |
CA (1) | CA2103826C (xx) |
DE (2) | DE4227616C2 (xx) |
DK (1) | DK0583578T3 (xx) |
ES (1) | ES2100396T3 (xx) |
GR (1) | GR3023311T3 (xx) |
HK (1) | HK1005876A1 (xx) |
ZA (1) | ZA935865B (xx) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2332548A1 (en) | 2001-07-13 | 2011-06-15 | Paratek Pharmaceuticals, Inc. | Tetracyclines for the treatment of stroke |
US20060194773A1 (en) * | 2001-07-13 | 2006-08-31 | Paratek Pharmaceuticals, Inc. | Tetracyline compounds having target therapeutic activities |
PL1951738T3 (pl) | 2005-11-25 | 2012-06-29 | Cvie Therapeutics Ltd | Nowe formy krystaliczne rostafuroksyny |
EP2537934A3 (en) | 2006-05-15 | 2013-04-10 | Paratek Pharmaceuticals, Inc. | Methods of regulating expression of genes or of gene products using substituted tetracycline compounds |
RS54459B1 (en) * | 2007-06-07 | 2016-06-30 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | 5BETA, 14BETA ANDROSTAN DERIVATIVES USEFUL FOR THE TREATMENT OF DISEASES RESULTING FROM THE BODY FIBROSIS |
US20120028945A1 (en) * | 2009-03-23 | 2012-02-02 | Patrizia Ferrari | 5-Beta, 14-Beta-Androstane Derivatives Useful For The Treatment Of Proteinuria, Glomerulosclerosis And Renal Failure |
WO2010149666A1 (en) | 2009-06-22 | 2010-12-29 | Medexis S.A. | Methods for treating neoplasia |
US20120238488A1 (en) | 2009-09-08 | 2012-09-20 | Konstantinos Alevizopoulos | Compounds and methods for treating neoplasia |
AU2010309921B2 (en) | 2009-10-19 | 2017-04-13 | Cvie Therapeutics Limited | Methods and systems for pharmacogenomic treatment of cardiovascular conditions |
CN108152432B (zh) * | 2017-12-29 | 2020-11-20 | 兆科药业(合肥)有限公司 | 一种罗他夫辛片高效液相检测方法 |
US11337988B2 (en) | 2018-09-27 | 2022-05-24 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Use of ouabain antagonists to inhibit viral infection |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH621803A5 (xx) * | 1974-08-08 | 1981-02-27 | Siphar Sa | |
HU171166B (hu) * | 1975-07-15 | 1977-11-28 | Richter Gedeon Vegyeszet | Sposob poluchenija novykh ehpoksi-androstanov |
DE2614046C2 (de) * | 1976-04-01 | 1984-08-02 | Boehringer Mannheim Gmbh, 6800 Mannheim | Neue 17α-Hydroxy-Cardenolid-Glykoside, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel |
US4380624A (en) * | 1981-07-31 | 1983-04-19 | Advance Biofactures Corp. | Novel isomers of bufalin and resibufogenin and their preparation |
DE4221636C1 (de) * | 1992-07-01 | 1994-03-31 | Sigma Tau Ind Farmaceuti | Cyclopentanperhydrophenanthren-17beta-(3-furyl)-3-Derivate |
-
1992
- 1992-08-20 DE DE4227616A patent/DE4227616C2/de not_active Expired - Fee Related
-
1993
- 1993-06-25 DK DK93110187.7T patent/DK0583578T3/da active
- 1993-06-25 DE DE69310052T patent/DE69310052T2/de not_active Expired - Lifetime
- 1993-06-25 EP EP93110187A patent/EP0583578B1/en not_active Expired - Lifetime
- 1993-06-25 AT AT93110187T patent/ATE152118T1/de active
- 1993-06-25 ES ES93110187T patent/ES2100396T3/es not_active Expired - Lifetime
- 1993-08-11 CA CA002103826A patent/CA2103826C/en not_active Expired - Lifetime
- 1993-08-12 ZA ZA935865A patent/ZA935865B/xx unknown
- 1993-08-16 US US08/106,893 patent/US5591734A/en not_active Expired - Lifetime
- 1993-08-19 JP JP20494793A patent/JP3357427B2/ja not_active Expired - Lifetime
- 1993-08-20 KR KR1019930016226A patent/KR100276528B1/ko not_active IP Right Cessation
- 1993-11-18 JP JP5289181A patent/JPH06219951A/ja active Pending
-
1995
- 1995-06-02 US US08/458,822 patent/US5567697A/en not_active Expired - Lifetime
-
1997
- 1997-05-02 GR GR970400967T patent/GR3023311T3/el unknown
-
1998
- 1998-06-05 HK HK98104942A patent/HK1005876A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
JP3357427B2 (ja) | 2002-12-16 |
CA2103826A1 (en) | 1994-02-21 |
GR3023311T3 (en) | 1997-08-29 |
ATE152118T1 (de) | 1997-05-15 |
ZA935865B (en) | 1994-03-10 |
EP0583578A3 (en) | 1994-07-06 |
DE4227616C2 (de) | 1995-04-13 |
DK0583578T3 (da) | 1997-07-21 |
DE69310052T2 (de) | 1997-09-18 |
KR100276528B1 (ko) | 2001-02-01 |
KR940003964A (ko) | 1994-03-14 |
DE69310052D1 (de) | 1997-05-28 |
US5591734A (en) | 1997-01-07 |
US5567697A (en) | 1996-10-22 |
EP0583578A2 (en) | 1994-02-23 |
DE4227616A1 (de) | 1994-03-10 |
CA2103826C (en) | 1998-12-22 |
JPH06157586A (ja) | 1994-06-03 |
ES2100396T3 (es) | 1997-06-16 |
EP0583578B1 (en) | 1997-04-23 |
JPH06219951A (ja) | 1994-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0590271A3 (en) | 17-aryl and 17-heterocyclyl-14beta-5alpha-androstane, androstene and androstadiene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same | |
WO1991018866A3 (en) | 1,4-diamino-2,3-dihydroxybutanes | |
IL67572A (en) | Trans-2-aza bicyclo(3.(3+n).o)alkane-3-carboxylic acid derivatives,processes for their preparation and pharmaceutical compositions containing them | |
IL84446A0 (en) | 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
IL83467A0 (en) | Imidazole derivatives,processes for their preparation and pharmaceutical compositions containing the same | |
IL96019A0 (en) | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
DE3374686D1 (en) | 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them | |
AU7929391A (en) | New 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles and 1,2,3,4-tetrahydro-beta-carbolines processes for preparing these and pharmaceutical compositions containing them | |
ZA935865B (en) | 17-(3-furyl) and 17-(4-pyridazinyl)-5Béta 14Béta-androstane derivatives active on the cardiovascular system processes for their preparation and pharmaceutical compositions containing same | |
IL105348A0 (en) | Azabicyclo derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
ZA934037B (en) | Novel biologically active eburnamenine derivatives, pharmaceutical compositions containing them and process for preparing same. | |
AU8315287A (en) | New alkanesulfonanilide and alkylaminosulfonanilide derivatives, processes for their preparation and pharmaceutical compositions comprising the same | |
IL87563A0 (en) | Isoxazole-beta-carboline derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
HUT45249A (en) | Process for producing 6,7,8,9-tetrahydro-10-methylpyrido/1,2-a/indol-9-amines, theyr derivatives and pharmaceutical compositions containing them as active components | |
GR3031118T3 (en) | Novel seco-D steroids active in the cardiovascular system and pharmaceutical compositions containing same | |
GR3025872T3 (en) | Orally active derivatives of 1,3,5(10)-estratriene | |
HUT47096A (en) | Process for producing 1,2-dithiol-3-thion derivatives and pharmaceutical compositions containing them as active components | |
ZA87332B (en) | Compositions containing fixed combinations | |
AU8917891A (en) | Poly-aminopyrrolecarboxamido derivatives, processes for their preparation and pharmaceutical compositions containing them | |
CA2103825A1 (en) | 17-hydroxyiminomethyl-5.beta., 14.beta.-androstane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same | |
IL86269A0 (en) | Imidazole derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
AU617929B2 (en) | Novel steroid derivatives, pharmaceutical compositions containing them and process for preparing same | |
EP0226842A3 (en) | Substituted 1,4-naphthalenediones, processes for their preparation and pharmaceutical compositions containing them | |
GR3022376T3 (en) | 17B-Aryl and 17B-heterocyclyl-5-beta,14-beta-andostane derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing same | |
EP0386920A3 (en) | 2-hydroxy-3-thienyloxypropylamino derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PF | Patent in force | ||
PE | Patent expired |
Effective date: 20130624 |